As of 2024-12-11, the Intrinsic Value of Madrigal Pharmaceuticals Inc (MDGL) is
-118.91 USD. This MDGL valuation is based on the model Peter Lynch Fair Value.
With the current market price of 318.44 USD, the upside of Madrigal Pharmaceuticals Inc is
-137.34%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
-118.91 USD
Intrinsic Value
MDGL Intrinsic Value - Valuation Summary
|
Range |
Selected |
Upside |
| a |
| Fair Value |
-118.91 - -118.91 |
-118.91 |
-137.34% |
| P/E |
(497.03) - (839.48) |
(683.71) |
-314.7% |
| DDM - Stable |
(214.40) - (645.89) |
(430.14) |
-235.1% |
| DDM - Multi |
(79.65) - (186.25) |
(111.53) |
-135.0% |
MDGL Intrinsic Value - Key Valuation Metrics
| Market Cap (mil) |
6,945.18 |
| Beta |
0.58 |
| Outstanding shares (mil) |
21.81 |
| Enterprise Value (mil) |
6,438.79 |
| Market risk premium |
4.60% |
| Cost of Equity |
9.54% |
| Cost of Debt |
5.00% |
| WACC |
9.44% |